pl flaga PL rus flaga  RU

Aesculan®

Aesculan®

 OTC Drugs
Alleviates the symptoms of haemorrhoids; topically anaesthetic, styptic and anti-inflammatory.
Email
Aesculan®Aesculan®
Description

Active ingredients:

1 g of the ointment contains active substances: dry extract of horse-chestnut bark (Aesculus hippocastanum L., cortex (40-90:1), extracting solvent: methanol 90 % (v/v)) - 62.5 mg; lidocaine hydrochloride (Lidocaini hydrochloridum) - 5 mg.

Therapeutic indications:
Haemorrhoidal disease

Dosage and administration:
Intrarectal administration. Adults: if not recommended otherwise by a doctor, use the enclosed cannula to apply the ointment on the affected area or squeeze around 0.5 to 1.0 g (a strip approx. 2 cm in length) into the rectum 2 or 3 times a day until acute symptoms subside. Then the dose can be reduced with the ointment administered one time a day. Use the preparation until the symptoms subside. Contact your doctor when no improvement is seen after 7 days of using this formulation or when symptoms related to haemorrhoid disease aggravate. 

Contraindications:
Do not use the Aesculan preparation if there is hypersensitivity to the medicinal substances or the adjuvants, allergy to amide-based topical anaesthetics and/or Asteraceae family plants.

Marketing authorisation holder:
Poznańskie Zakłady Zielarskie Herbapol S.A. in Poznań

Available packages: 30 g


Read leaflet before use. The leaflet describes indications, contraindications, and gives information about adverse reactions and dosage, as well as about administration of the medicinal product. Otherwise consult a doctor or a pharmacist as improper use of any pharmaceutical product can pose a danger to life and health.

 

Tips

Anal varicose veins (haemorrhoids) – an embarrassing problem

Despite the fact that diagnosis with haemorrhoids has been increasing in number, they still remain a rare topic of discussion between patients and doctors. The persons affected usually feel awkward about the problem and more than once cannot present the

Read more...